, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting

 In Q4/2018, the Company and its subsidiaries recorded total sales of Baht 1,456 million, a decrease of 5% YoY, mainly due to drop in export CMG, domestic CMG, and domestic branded sales. However

/2019, the Company and its subsidiaries recorded total sales of Baht 1,240 million, a decrease of 7% YoY, occurred from a decline in domestic branded sales at 12% YoY while export branded sales continued

ที่ FPI Ref. FPI.001/2020 25 February 2020 Subject : Management Discussion & Analysis of Performance Results of the year ended 2019 To : Board of Directors and President of The Stock Exchange of

ที่ FPI Ref. FPI.002/2019 21 February 2019 Subject : Management Discussion & Analysis of Performance Results Of the Year Ended 31 December 2018 To : Board of Directors and President of The Stock

November 13, 2018 Subject: MD&A for the financial statements of the 3rd quarter of fiscal year 2018 ended as of September 30, 2018 To: The President The Stock Exchange of Thailand Aapico Hitech Public

IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited

Q3/2019, the Company and its subsidiaries recorded total sales of Baht 1,205 million, an increase of 0.1% YoY, occurred from a decline in domestic branded sales at 11% YoY while export branded sales

1188 FAX : +66 (0) 2625 1103 www.jubileediamond.co.th CS 08/2018 May 8, 2018 Subject Declaration of Operating Results for the first quarter of year 2018 Attention Directors and Managers The Stock

) May 9, 2018 Re : Report the operating result for the year ended March 31 ,2018 by more than 20 percent. To : Director and Manager the Stock Exchange of Thailand Approved by the Board of Directors of